ClinicalTrials.gov record
No Longer Available No phase listed Expanded access

A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell Malignancies

ClinicalTrials.gov ID: NCT04052854

Public ClinicalTrials.gov record NCT04052854. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 1:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single-Arm, Expanded Access Study of Zanubrutinib (BGB3111) in Participants With B-cell Malignancies

Study identification

NCT ID
NCT04052854
Recruitment status
No Longer Available
Study type
Expanded access
Phase
Not listed
Lead sponsor
BeiGene
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Zanubrutinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Oct 22, 2024

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
10
Facility City State ZIP Site status
Eisenhower Desert Cardiology Center Rancho Mirage California 92270
Sansum Clinic and Ridley Tree Cancer Center Santa Barbara California 93105
Maryland Oncology Hematology, Pa Columbia Maryland 21044
Dana Farber Cancer Institute Boston Massachusetts 02215
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169
Morristown Medical Center Morristown New Jersey 07960
Icahn School of Medicine At Mount Sinai New York New York 10029
Clinical Research Alliance, Inc Westbury New York 11590
Texas Oncology Austin Midtown Round Rock Texas 78681
Texas Oncology Tyler Longview Tyler Texas 75702

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04052854, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2024 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04052854 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →